President's Message, NTB :)
PRESIDENT'S MESSAGE from Neptune's Website - see
the link below :)
NeptuneTechnologies has made significant progress solidifying and positioningthe Company to meet the challenges of its next growth and expansionphase. Significant achievements have been made with the objective tocontinue its transition from the dietary supplements segment tofunctional and medical foods and into pharmaceuticals.
Neptuneis currently negotiating strategic alliances for raw material supplyand high scale production for the nutraceutical and pharmaceuticalapplications with major suppliers and multinational industrialmanufacturing partners. Neptune is progressing with plans to increaseplant capacity and continue to improve productivity.
TheCompany is continuously researching, developing and testing newproducts and formulations for nutraceutical applications within theOPA3 family with health benefits for cardiovascular, neurological andinflammatory diseases. This effort will result in entering new dietarysupplement distributor agreements, advancing the Nestlé and Yoplaitfunctional food products through its development and testing phases,and in partnering with other multinational food companies exploitingits three therapeutic applications within the four food categories(dairy, cereals/bars, juice/beverages, confectionary).
Neptunehas advanced its internal pharmaceutical operations which led to theset up of Acasti Pharma for cardiovascular applications andNeuroBioPharm for neurological applications with the objective tofurther advance the pharmaceutical programs including anover-the-counter drug, a prescription medical food and a prescriptiondrug and to continue to pursue strategic alliances with pharmaceuticalcompanies.
Neptune continues to focus onbuilding the fundamentals of the Company which leads Neptune toward itsprimary objective of increasing Company value and shareholder wealth.
Henri Harland, President & Chief Executive Officer
https://www.neptunebiotech.com/index.php?option=com_content&view=article&id=102&Itemid=120